Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1312 | 1050 | 1312 | 1354 | 2064 | 4955 |
Fund Return | 31.18% | 5.04% | 31.18% | 10.64% | 15.59% | 17.35% |
Place in category | 183 | 528 | 183 | 146 | 44 | 3 |
% in Category | 10 | 28 | 10 | 9 | 4 | 1 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CIBC Nasdaq Index | 4.06B | 34.67 | 12.93 | 19.38 | ||
CIBC Nasdaq Index Premium Class | 4.06B | 35.73 | 13.85 | 20.41 | ||
CIBC US Broad Market Index | 2.78B | 32.75 | 10.98 | 13.23 | ||
CIBC US Broad Market Index Premium | 2.78B | 33.71 | 11.80 | 14.10 | ||
CIBC Managed Growth Portfolio U$ | 40.56M | 13.30 | 3.87 | 6.56 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators F USD | 16.83B | 60.55 | 18.32 | - | ||
Capital Group Global Equity Fd F | 14.38B | 28.47 | 5.35 | 11.90 | ||
Capital Group Global Equity Fd A | 14.38B | 27.06 | 4.20 | 10.67 | ||
Capital Group Global Equity Fd D | 14.38B | 28.08 | 5.00 | 11.43 | ||
Mackenzie Global Dividend Fund A | 7.31B | 23.33 | 7.82 | 10.27 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Apple | US0378331005 | 9.07 | 222.78 | -0.39% | |
Microsoft | US5949181045 | 8.51 | 444.06 | -0.59% | |
NVIDIA | US67066G1040 | 8.40 | 142.62 | -3.12% | |
Alphabet A | US02079K3059 | 8.06 | 200.21 | +1.13% | |
Meta Platforms | US30303M1027 | 6.10 | 647.49 | +1.73% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review